Recruiting studies: Sickle Cell Trait

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03685721 Blood Sampling for Research Related to Sickle Cell Disease
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00542230 Sickle Cell Kidney Biorepository
Phase N/A · 2 location(s) · University of Texas Southwestern Medical Center · NCT07064174 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Di
Phase 1 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT05904093 PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]
Phase N/A · 12 location(s) · Nova Laboratories Limited · NCT06923111 Uganda Sickle Surveillance Study (US-3)
Phase N/A · 4 location(s) · Children's Hospital Medical Center, Cincinnati · NCT06301893 A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult
Phase 3 · 32 location(s) · Novartis Pharmaceuticals · NCT06439082 A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
Phase 2 · 9 location(s) · University of Regensburg · NCT04201210 Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
Phase N/A · 1 location(s) · UConn Health · NCT07083531 Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT04416178 Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
Phase N/A · 10 location(s) · National Alliance for Sickle Cell Centers · NCT06071377 131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Phase 1 · 1 location(s) · Columbia University · NCT07015684

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.